Ritter Andrew J Insider Trades

Insider Trading History

Track insider trading activity for Ritter Andrew J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Qualigen Therapeutics
Qualigen Therapeutics QLGN
CEO And President
Holding Value $1.87M 583,068 shares
Last Trade
May 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.66B 583,068 shares
$8,000.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
CEO And President
Holding Value $262k 81,727 shares
Last Trade
Mar 04, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$105M 18,750 shares
$5,623.75
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
CEO And President
Holding Value $809k 252,000 shares
Last Trade
Feb 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.89B 252,000 shares
$7,497.50
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
CEO And President
Holding Value $482k 150,000 shares
Last Trade
Jun 26, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.12B 150,000 shares
$34,125.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President
Holding Value $1.59M 495,065 shares
Last Trade
Jan 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21B 495,065 shares
$42,375.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, President
Holding Value $3.23M 1,004,772 shares
Last Trade
Oct 03, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.1B 375,000 shares
$45,475.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, President
Holding Value $450k 140,044 shares
Last Trade
Oct 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.5B 140,044 shares
$325,000.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, President
Holding Value $263k 82,000 shares
Last Trade
Jul 05, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7B 82,000 shares
$191,850.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, President
Holding Value $20.1k 6,250 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.24B 6,250 shares
$198,750.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President
Holding Value $0 0 shares
Last Trade
Jun 29, 2015 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$451B 817,272 shares
$551,250.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President
Holding Value $2.62M 817,272 shares
Last Trade
Jun 29, 2015 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$451B 817,272 shares
$551,250.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President
Holding Value $0 0 shares
Last Trade
Jun 24, 2015 Sale
$311B 502,364 shares
$620,000.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President
Holding Value $0 0 shares
Last Trade
Jun 24, 2015 Sale
$507B 817,272 shares
$620,000.00
$3.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up